Subbu Nambi
Stock Analyst at Guggenheim
(4.17)
# 442
Out of 5,067 analysts
53
Total ratings
58.14%
Success rate
13.37%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.01 | - | 4 | Nov 21, 2025 | |
| GRAL GRAIL | Upgrades: Buy | $100 | $111.40 | -10.23% | 2 | Nov 12, 2025 | |
| PSNL Personalis | Maintains: Buy | $6 → $12 | $9.99 | +20.18% | 1 | Nov 11, 2025 | |
| VCYT Veracyte | Maintains: Buy | $40 → $45 | $46.70 | -3.64% | 4 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $115 → $170 | $161.08 | +5.54% | 2 | Oct 29, 2025 | |
| RVTY Revvity | Initiates: Neutral | n/a | $100.58 | - | 1 | Oct 16, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $20 | $20.46 | -2.25% | 1 | Sep 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $76.06 | +24.90% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $111.25 | -39.78% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $25.15 | +43.14% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $226.98 | +10.14% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.86 | +70.65% | 3 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $114 | $125.96 | -9.50% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $29.33 | +70.47% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.49 | +5.37% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.73 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $47.56 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $238.58 | -16.17% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.86 | +23.46% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.07 | +189.86% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.13 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $167.26 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $38.56 | -35.17% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.50 | - | 1 | Dec 14, 2023 |
Exact Sciences
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.01
Upside: -
GRAIL
Nov 12, 2025
Upgrades: Buy
Price Target: $100
Current: $111.40
Upside: -10.23%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $6 → $12
Current: $9.99
Upside: +20.18%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $46.70
Upside: -3.64%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $161.08
Upside: +5.54%
Revvity
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $100.58
Upside: -
Adaptive Biotechnologies
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $20.46
Upside: -2.25%
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $76.06
Upside: +24.90%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $111.25
Upside: -39.78%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $25.15
Upside: +43.14%
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $226.98
Upside: +10.14%
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.86
Upside: +70.65%
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $125.96
Upside: -9.50%
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $29.33
Upside: +70.47%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.49
Upside: +5.37%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.73
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $47.56
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $238.58
Upside: -16.17%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.86
Upside: +23.46%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.07
Upside: +189.86%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.13
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $167.26
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $38.56
Upside: -35.17%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.50
Upside: -